Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Variants, Their Serum Levels, and Activities with Aortic Valve Calcification (AVC) in a Population from Western Iran
Genetic Testing and Molecular Biomarkers · 2024
DOI: 10.1089/gtmb.2023.0370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetic Testing and Molecular Biomarkers, 2024. Verfasst von Reza Heidari Moghadam und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 9, Calcinosis, Matrix Metalloproteinase 2, Aortic Valve. Die Arbeit nennt 51 Literaturangaben.
Abstract (Originalsprache)
Background
Matrix metalloproteinase (MMP) enzyme gene polymorphisms MMP-2-1575G/A and MMP-9-1562C/T promoter polymorphism, their serum levels, and activity are associated with aortic valve calcification (AVC). Materials and Methods: The synergistic link between the risk of AVC and the alleles T and A of MMP-9 and MMP-2 was investigated, respectively. Ninety-two cases with AVC and 92 healthy individuals from the west of Iran were included, and MMP- 2-1575G/A and MMP-9-1562C/T promoter polymorphisms were detected using PCR-RFLP. The serum levels and activity of MMP-2 and -9 were assessed using ELISA and gelatin zymography methods, respectively. In addition, serum biochemical markers, including FBS, urea and creatinine, cholesterol, triglyceride, HDL, LDL, calcium, phosphorus, and blood pressure: systolic blood pressure and diastolic blood pressure were measured.
Results
Heart valve calcification disease was associated with a comparatively higher frequency of the A allele of the MMP2-1575 variation (p = 0.002). In addition, the frequency of T allele of the MMP9-1562 variant was higher than the control group (p = 0.007).
Conclusion
MMP-2 and MMP-9 serum levels and activities were observed to be considerably higher in the experimental group than in the control group (p < 0.001). Patients are more susceptible to cardiovascular disease than the control group due to elevated serum levels and activity of MMP-2 and MMP-9.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Regenerative Medicine Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
- Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
ORCID-Profile: Daniel Elieh-Ali-Komi
Zitieren
APA
Heidari Moghadam, R., Babajani, F., Karami, A., Elieh-Ali-Komi, D., Hoseini, F., Salehi, N., Elahirad, S., Mohammadi-Noori, E., Mohammadi, H., & Kiani, A. (2024). Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Variants, Their Serum Levels, and Activities with Aortic Valve Calcification (AVC) in a Population from Western Iran. Genetic Testing and Molecular Biomarkers. https://doi.org/10.1089/gtmb.2023.0370
Vancouver
Heidari Moghadam R, Babajani F, Karami A, Elieh-Ali-Komi D, Hoseini F, Salehi N, et al. Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Variants, Their Serum Levels, and Activities with Aortic Valve Calcification (AVC) in a Population from Western Iran. Genetic Testing and Molecular Biomarkers. 2024. doi:10.1089/gtmb.2023.0370
BibTeX
@article{HeidariMoghadam2024,
author = {Heidari Moghadam, Reza and Babajani, Fatemeh and Karami, Afshin and Elieh-Ali-Komi, Daniel and Hoseini, Faeghe and Salehi, Nahid and Elahirad, Saeed and Mohammadi-Noori, Ehsan and Mohammadi, Hossein and Kiani, Amir},
title = {Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Variants, Their Serum Levels, and Activities with Aortic Valve Calcification (AVC) in a Population from Western Iran},
journal = {Genetic Testing and Molecular Biomarkers},
year = {2024},
doi = {10.1089/gtmb.2023.0370}
}
EUVIMED